Letter to the Editor

Recently published articles about Letter to the Editor

JCP
Erecting Barriers to Suicide by Removing Barriers to Science
Letter to the Editor

April 30, 2025

The authors comment on the implications of a recent NSF communication warning researchers about the use of certain terms in grant proposals and publications made possible with government funding.
, , , et al
PCC
Revisiting Ayahuasca: Vine of the Soul of the Amazon
Letter to the Editor

March 18, 2025

The authors comment on a case report previously published in the PCC describing psychosis and ayahuasca use and discuss the need for further research given its increased usage worldwide.
,
PCC
Cannabis Withdrawal Psychosis
Letter to the Editor

March 13, 2025

Dr Gorelick comments on a case report recently published in the PCC.
PCC
Cannabis Withdrawal Psychosis: Reply to Gorelick
Letter to the Editor

March 13, 2025

The authors reply to a letter to the editor commenting on their case report.
,
PCC
Parenting Young Adults With ADHD
Letter to the Editor

February 13, 2025

The authors explore the role of parental involvement in supporting young adults with ADHD.
, ,
JCP
The Need for Clinical Guidance on Ketamine/Esketamine Use in Clinical Settings
Letter to the Editor

February 5, 2025

The authors comment on a recent study by Santucci et al.
,

Recent JCP Articles on Letter to the Editor

JCP
What Clinicians Should Know About the Pragmatic Use of Xanomeline-Trospium Combination
ASCP Corner

June 9, 2025

This article will help familiarize clinicians with practical issues in the use of xanomeline-trospium and its entry into the pharmacopoeia for schizophrenia.
,
JCP
Administering Semaglutide With Long-Term Olanzapine Use
Case Report

June 9, 2025

This report describes use of the GLP-1R agonist semaglutide in a patient with schizophrenia and severe, olanzapine-induced weight gain that was resistant to alternative treatments.
, , , et al
JCP
The Dopamine-3 Receptor in the Treatment of Schizophrenia: Part 1
Insights

June 6, 2025

In Part I of his video, Dr. Ragy Girgis highlights the D3 receptor as a promising target in schizophrenia, with potential to address negative and cognitive symptoms unmet by...

Recent PCC Articles on Letter to the Editor

PCC
Efficacy of GLP-1 Agonists in Mental Disorders
Review Article

June 10, 2025

Current evidence underscores the potential of GLP-1 receptor agonists as a novel therapeutic approach for certain psychiatric disorders, particularly AUDs, depression, and autism-related food behaviors.
, , , et al
PCC
β-blocker/Colchicine Coingestion With Cocaine Intoxication
Case Report

June 5, 2025

The authors describe a case in which cocaine-induced cardiac toxicity initially masked β-blocker (carvedilol) toxicity and suggest improvements in management for similar cases.
,
PCC
Excited Catatonia in Opioid and Benzodiazepine Withdrawal
Case Report

June 5, 2025

A 37-year-old man developed excited catatonia in the setting of concurrent opioid and benzodiazepine withdrawal, requiring high dosages of benzodiazepines to resolve.
, ,

Featured Letter to the Editor Research

How Patients Talk May Matter More Than What They Say
news

June 9, 2025

A new study suggests that subtle language cues in how patients talk about their mental health may reveal critical, often overlooked insights.
Restrictive Diets Could Make Depression Worse
news

June 6, 2025

Restrictive diets could make depressive symptoms worse, suggesting that one-size-fits-all eating plans could carry hidden mental health risks.
Weekly Mind Reader: A Smarter Approach to Pain
news

June 6, 2025

As we head into the summer months, we consider a better approach to chronic pain, explore idiopathic hypersomnia, and wonder about the practice of deprescribing.

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe